News FDA clears GSK's Priorix, first new MMR vaccine in 50 years With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmi
News Andexxa reaches the end of the line in the US AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US amid reports of serious clotting side effects.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
